Inicio > HERRERAS CANTALAPIEDRA, JOSE MARIA

HERRERAS CANTALAPIEDRA, JOSE MARIA

PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Cirugía, Oftalmología, Otorrinolaringología y Fisioterapia
Grupo de Investigacion en Superficie Ocular (GSO)
 
josemaria.herreras.cantalapiedra@uva.es

Índice H en Scopus: 27
 

[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80632]], camposKey:2193-8245 2023-12-01 In Vivo Confocal Microscopy in Limbal Stem Cell Deficiency After Mesenchymal Stem Cell Transplantation: A Sub-analysis from a Phase I¿II Clinical Trial32513262, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80827]], camposKey:0365-6691 2023-10-01 Detecting progression of acute zonal occult outer retinopathy (AZOOR) with optical coherence tomography angiography: A case report Detección de la progresión de la retinopatía externa oculta zonal aguda (AZOOR) con angiografía por tomografía de coherencia óptica: a propósito de un caso595600, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75375]], camposKey:0049-0172 2023-02-01 Anti-TNF vs tocilizumab in refractory uveitic cystoid macular edema due to Behcet's disease. Multicenter study of 49 patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81334]], camposKey:0365-6691 2023-01-01 Detección de la progresión de la retinopatía externa oculta zonal aguda (AZOOR) con angiografía por tomografía de coherencia óptica: a propósito de un caso595600, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75376]], camposKey:0365-6691 2022-08-01 Clinical case: Serpiginous-like choroiditis with macular involvement and good response after treatment with adalimumab Caso clínico: coroiditis serpiginosa-like con afectación macular y buena evolución tras tratamiento con adalimumab477480, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69948]], camposKey:0365-6691 2022-01-01 Caso clínico: coroiditis serpiginosa-like con afectación macular y buena evolución tras tratamiento con adalimumab477480, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76833]], camposKey:1999-4923 2021-01-01 Goals and challenges of stem cell-based therapy for corneal blindness due to limbal deficiency14830, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=76831]], camposKey:1757-6512 2021-01-01 Subconjunctival injection of mesenchymal stem cells for corneal failure due to limbal stem cell deficiency: state of the art00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65310]], camposKey:0025-7753 2020-09-11 Recommendations statement on the immunosuppressive treatment of non-infectious, non-neoplastic, non-anterior uveitis Documento de recomendaciones sobre el tratamiento con inmunodepresores de la uveítis no anterior, no infecciosa, no neoplásica00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=57735]], camposKey:0025-7753 2020-01-01 Documento de recomendaciones sobre el tratamiento con inmunodepresores de la uveítis no anterior, no infecciosa, no neoplásica2200, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42322]], camposKey:0165-5701 2019-01-15 Vision-threatening bilateral panuveitis and TRAPS in a child: an uncommon association219223, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41609]], camposKey:1931-5244 2019-01-01 A proof-of-concept clinical trial using mesenchymal stem cells for the treatment of corneal epithelial stem cell deficiency1840, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52915]], camposKey:1699-1036 2019-01-01 Eficacia del trasplante de células madre mesenquimales de médula ósea y de tejido adiposo en un modelo de deficiencia de células madre limbares desarrollado en conejo: estudio comparativo172172, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52916]], camposKey:1699-1036 2019-01-01 Eficacia del trasplante de células madre mesenquimales de médula ósea y de tejido adiposo en un modelo de deficiencia de células madre limbares desarrollado en conejo: estudio comparativo3639, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42323]], camposKey:0161-6420 2018-09-01 Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease14441451, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42324]], camposKey:0365-6691 2018-07-01 Unusual ocular clinical manifestation of leptospirosis Manifestación clínica ocular inusual de la leptospirosis342346, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42325]], camposKey:1177-5467 2018-03-06 Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease453461, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52914]], camposKey:1699-1036 2018-01-01 Estudio de la tolerabilidad y la eficacia del trasplante de células madre mesenquimales de médula ósea en un modelo de síndrome de insuficiencia límbica189190, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42326]], camposKey:0721-832X 2018-01-01 Impact of herpetic stromal immune keratitis in corneal biomechanics and innervation155161, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42327]], camposKey:0025-7753 2017-12-20 Treatment recommendations for non-infectious anterior uveitis Documento de recomendaciones de tratamiento de la uveítis anterior no infecciosa00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42328]], camposKey:0025-7974 2017-10-01 Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47865]], camposKey:0146-0404 2017-01-01 A Randomized Controlled Trial of Cultivated Limbal Epithelial Cells Compared to Mesenchymal Stem Cells for the Treatment of Corneal Failure due to Limbal Stem Cell Deficiency00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41612]], camposKey:1755-375X 2017-01-01 Cytokine and chemokine tear levels in patients with uveitis405414, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52913]], camposKey:1699-1036 2017-01-01 Inflamación de la superficie ocular en un modelo parcial y total de síndrome de insuficiencia límbica204204, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3532]], camposKey:0271-3683 2017-01-01 Successful Consecutive Expansion of Limbal Explants Using a Biosafe Culture Medium under Feeder Layer-Free Conditions685695, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3528]], camposKey:1066-5099 2017-01-01 Therapeutic Effect of Human Adipose Tissue-Derived Mesenchymal Stem Cells in Experimental Corneal Failure Due to Limbal Stem Cell Niche Damage21602174, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3540]], camposKey:0014-4835 2016-01-01 Comparison of functional limbal epithelial stem cell isolation methods8394, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=682]], camposKey:0213-3911 2015-02-01 In vivo confocal microscopy assessment of the corneoscleral limbal stem cell niche before and after biopsy for cultivated limbal epithelial transplantation to restore corneal epithelium183192, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42329]], camposKey:0049-0172 2015-01-01 Anti-TNF- alpha therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients361368, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9356]], camposKey:1018-9068 2015-01-01 Consensus Document on Allergic Conjunctivitis (DECA)94106, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49171]], camposKey:0146-0404 2015-01-01 Improvement of limbal and corneal phenotype after transplantation of human adipose tissue-derived mesenchymal stem cells in an in vivo model of ocular surface failure00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3546]], camposKey:2314-6133 2015-01-01 Stem Cell Therapy for Corneal Epithelium Regeneration following Good Manufacturing and Clinical Procedures00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9359]], camposKey:1462-0324 2014-12-01 Anti-TNF-alpha therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients22232231, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9358]], camposKey:2326-5191 2014-10-01 Comparative Study of Infliximab Versus Adalimumab in Patients with Refractory Uveitis Due to Behcet's Disease. Multicenter Study of 125 Cases.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9357]], camposKey:1367-0484 2014-08-01 Optical quality and intraocular scattering assessed with a double-pass system in eyes with contact lens induced corneal swelling278284, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9354]], camposKey:0003-4967 2014-06-01 ANTI-TNF alpha THERAPY IN REFRACTORY SARCOID UVEITIS: MULTICENTER STUDY OF 16 CASES317317, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9355]], camposKey:0003-4967 2014-06-01 COMPARATIVE STUDY OF INFLIXIMAB VERSUS ADALIMUMAB IN PATIENTS WITH REFRACTORY UVEITIS DUE TO BEHCET'S DISEASE. MULTICENTER STUDY OF 125 CASES557557, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49168]], camposKey:0146-0404 2014-01-01 Biosafe culture medium optimization for in vitro expansion of limbal epithelial stem cells for clinical transplantation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49169]], camposKey:0146-0404 2014-01-01 Safety and preliminary efficacy of human adipose tissue mesenchymal stem cells (hATMSC) to restore the ocular surface in an in vivo experimental model of limbal stem cell deficiency (LSCD)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9349]], camposKey:0004-3591 2013-10-01 Biologic Therapy In Refractory Uveitis Of Behcet's Syndrome: Switching and Dose Modification. Multicenter Study Of 124 Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9353]], camposKey:0004-3591 2013-10-01 Short and Long-Term Biological Therapy In Refractory Uveitis Of Behcet's Syndrome. Multicenter Study Of 124 Patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9346]], camposKey:0277-3740 2013-02-01 Corneal Inflammation From Pine Processionary Caterpillar Hairs161164, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=755]], camposKey:0271-3683 2013-01-01 Consecutive Expansion of Limbal Epithelial Stem Cells from a Single Limbal Biopsy537549, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=729]], camposKey:0014-4835 2013-01-01 Effect of TGF-beta on ocular surface epithelial cells88100, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41666]], camposKey:1040-5488 2013-01-01 Erratum: Refractive Stabilization and Corneal Swelling After Cataract Surgery (Optometry and Vision Science (2013) 90 (31-36))00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9350]], camposKey:1040-5488 2013-01-01 Refractive Stabilization and Corneal Swelling After Cataract Surgery3136, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53935]], camposKey:1442-6404 2013-01-01 Repeatability and agreement of ARK-30 autorefraction after cataract surgery (vol 40, pg 134, 2012)719719, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=674]], camposKey:0927-3948 2012-12-01 Distinctive Clinical Features of Idiopathic versus Infectious Serpiginous Choroidopathy448452, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9348]], camposKey:0950-222X 2012-09-01 Assesment of fundus autofluorescence in serpiginous and serpiginous-like choroidopathy12321236, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9342]], camposKey:0003-9950 2012-09-01 Infectious Nontuberculous Serpiginous Choroiditis12071208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42330]], camposKey:1177-5467 2012-04-26 Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction637644, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9347]], camposKey:1120-6721 2012-01-01 Gomez-López-Hernández syndrome: another consideration in corneal neurotrophic ulcers826829, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9352]], camposKey:1442-6404 2012-01-01 Repeatability and agreement of ARK-30 autorefraction after cataract surgery134140, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=675]], camposKey:0008-4182 2011-02-01 Antioxidant enzyme mRNA expression in conjunctival epithelium of healthy human subjects3539, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46974]], camposKey:1663-2699 2011-01-01 Adrenocortical adenoma and central serous chorioretinopathy: A rare association?327332, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46975]], camposKey:1663-2699 2011-01-01 Frosted branch angiitis diagnosed as neuro-behçet: A diagnostic and etiologic dilemma175175, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3551]], camposKey:0365-6691 2011-01-01 Lack of concordance between dry eye syndrome questionnaires and diagnostic tests Falta de concordancia entre los cuestionarios y las pruebas diagnósticas en el síndrome de ojo seco37, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=772]], camposKey:0146-0404 2011-01-01 Ocular Mucin Gene Expression Levels as Biomarkers for the Diagnosis of Dry Eye Syndrome83638369, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=46973]], camposKey:1869-5760 2011-01-01 Surgical outcomes of uveitic glaucoma4353, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=50860]], camposKey:1560-2133 2010-01-01 Choroidal neovascularisation in punctate inner choroidopathy: therapeutic options.1928, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=790]], camposKey:0927-3948 2010-01-01 Dry Eye Disease as an Inflammatory Disorder244253, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41669]], camposKey:0365-6691 2010-01-01 Influence of axial length in refractive outcome after cataract surgery Influencia de la longitud axial en el resultado refractivo tras cirugía de catarata144148, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=14599]], camposKey:0210-5284 2010-01-01 Manejo optométrico del paciente con distrofia endotelial de Fuchs: después de cirugía de catarata.A propósito de un caso.3437, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=731]], camposKey:1090-0535 2010-01-01 Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease862873, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=784]], camposKey:1040-5488 2009-01-01 Conjunctival Mucin mRNA Expression in Contact Lens Wear10511058, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3553]], camposKey:0365-6691 2008-01-01 Limbal transplantation: Multicenter retrospective case series analysis Estudio multicéntrico retrospectivo sobre trasplante de limbo417422, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=677]], camposKey:1528-4050 2007-10-01 Clinical grading of atopic keratoconjunctivitis442445, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42331]], camposKey:0277-3740 2007-08-01 CHARGE association, hyper-immunoglobulin M syndrome, and conjunctival MALT lymphoma864867, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11096]], camposKey:0098-8243 2007-06-01 Conjunctival pigmentation in Stevens-Johnson syndrome99103, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=705]], camposKey:1530-4086 2007-03-01 Conjunctival pigmentation in Stevens-Johnson syndrome152157, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=668]], camposKey:0179-1958 2007-03-01 Subretinal fibrosis and uveitis syndrome associated with ulcerative colitis333334, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56142]], camposKey:0146-0404 2005-01-01 Can ocular mucin gene levels be used as an Investigational diagnostic test for dry eye?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42332]], camposKey:0365-6691 2005-01-01 Conjunctival blistering associated with pemphigus vulgaris: report of a case Ampolla conjuntival en el contexto de pénfigo vulgar: a propósito de un caso.365368, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9351]], camposKey:0277-3740 2005-01-01 Efficacy of systemic cyclosporine A and amniotic membrane on rabbit conjunctival limbal allograft rejection182188, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71399]], camposKey:0146-0404 2005-01-01 Hydrogel contact lens (HCL) wear in controlled adverse environment (CAE) conditions00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71398]], camposKey:0146-0404 2005-01-01 Limbal transplantation in ocular surface disease: Multicenter retrospective case series analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9343]], camposKey:0961-2033 2005-01-01 Serpiginous choroiditis in a patient with systemic lupus erythematosus928929, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3559]], camposKey:0365-6691 2004-12-01 Ocular Behçet disease. Retrospective study Enfermedad de Behçet ocular. Estudio retrospectivo.599603, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=749]], camposKey:0146-0404 2004-01-01 Comparison of antioxidant enzymes genes expression changes in conjunctival epithelium induced by non ionic hydrogel contact lenses with different oxigen permeability.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=748]], camposKey:0146-0404 2004-01-01 Comparison of mucin genes expression alterations in conjunctival epithelium induced by high and low water content hydrogel contact lenses.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11676]], camposKey:0365-6691 2004-01-01 Corneal epithelial complications after vitrectomy: a retrospective study Complicaciones corneales epiteliales de las vitrectomías: estudio retrospectivo.155161, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=782]], camposKey:0146-0404 2004-01-01 Corneal thickness changes after one year of hydrogel contact lens00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=778]], camposKey:0014-4835 2004-01-01 Impression cytology of the ocular surface: a review457472, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42333]], camposKey:0365-6691 2004-01-01 Ocular presentation in Wegener granulomatosis Presentación ocular de la granulomatosis de Wegener.135138, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56668]], camposKey:0146-0404 2003-05-01 Expression of neurotransmitter receptors and Vip in conjunctival biopsies of vernal keratoconjunctivitis patients00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=737]], camposKey:0146-0404 2003-01-01 Alteration of conjunctival mucin gene expression in tear-deficient Dry Eye Syndrome00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53793]], camposKey:0146-0404 2003-01-01 Antioxidant Enzyme Genes Expression in Conjunctival Epithelium of Normal Subjects00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=745]], camposKey:0146-0404 2003-01-01 Comparison of central corneal thickness measured with ultrasonic pachometer, Orbscan (R) and OCT (R)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=687]], camposKey:0277-3740 2003-01-01 Human epithelium from conjunctival impression cytology expresses MUC7 mucin gene665671, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=781]], camposKey:0146-0404 2003-01-01 Levels of antioxidant enzyme genes in conjunctival impression cytology specimens from hydrogel contact lenses wearers00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=723]], camposKey:0271-3683 2003-01-01 Levels of mucin gene expression in normal human conjunctival epithelium in vivo323328, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=770]], camposKey:0146-0404 2003-01-01 Low water content hydrogel contact lenses (HCL) induce corneal irregularity00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3560]], camposKey:0365-6691 2003-01-01 Normal human conjunctival epithelium expresses MUC13, MUC15, MUC16 and MUC17 mucin genes Expresión de los genes de mucinas MUC13, MUC15, MUC16 y MUC17 en el epitelio conjuntival normal humano in vivo.375381, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=775]], camposKey:0146-0404 2003-01-01 Prospective variation in the expression of the conjunctival mucin genes Muc5ac, Muc7, Muc16, and Muc17 before, during and after contact lens wear00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42334]], camposKey:0365-6691 2002-03-01 Immunomodulation in ophthalmology Inmunomodulación en oftalmología.117118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9345]], camposKey:1090-0535 2002-01-25 Evaluation of lectin staining in the diagnosis of fungal keratitis in an experimental rabbit model1016, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42336]], camposKey:0365-6691 2002-01-01 Anterior stromal puncture for recurrent corneal erosion Micropunciones del estroma anterior corneal como tratamiento de la erosión corneal recidivante.257262, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=756]], camposKey:0146-0404 2002-01-01 Comparison of ocular surface alterations induced by high and low water content hydrogel contact lenses00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=744]], camposKey:0146-0404 2002-01-01 Cyclosporin A does not alter the expression of ocular mucin genes in a normal human conjunctival (NHC) cell line00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=740]], camposKey:0065-2598 2002-01-01 Human conjunctival epithelium in culture: A tool to assay new therapeutic strategies for dry eye307311, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47259]], camposKey:0365-6691 2002-01-01 Inmunomodulación en oftalmología117118, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=47261]], camposKey:0365-6691 2002-01-01 Micropunciones del estroma anterior corneal como tratamiento de la erosión corneal recidivante257262, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42335]], camposKey:0365-6691 2002-01-01 Ocular sarcoidosis. Retrospective study of 18 cases Sarcoidosis ocular. Estudio retrospectivo de 18 casos.301308, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=733]], camposKey:0146-0404 2002-01-01 Range of mucin gene expression in normal human conjunctival epithelium in vivo00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9339]], camposKey:1081-597X 2001-09-01 Effect of hyaluronic acid on corneal haze in a photorefractive keratectomy experimental model549554, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=678]], camposKey:0927-3948 2001-09-01 Fuchs' heterochromic iridocyclitis: A review of 26 cases169175, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71400]], camposKey:0146-0404 2001-03-15 Modified staining protocol enables light microscopy evaluation of conjunctival impression cytology samples collected by polyethersulfone (PES) filter paper.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71401]], camposKey:0146-0404 2001-03-15 Ocular mucin gene expression in conjunctival impression cytology samples from healthy donors.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42337]], camposKey:0025-7753 2001-01-01 Alergia conjuntival: Formas clínicas350354, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9341]], camposKey:0927-3948 2001-01-01 Conjunctival biopsy in the diagnosis of ocular sarcoidosis5964, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3563]], camposKey:0365-6691 2001-01-01 In vitro toxicity of non-preserved artificial-tear formulations Lágrimas artificiales sin conservantes: estudio comparativo in vitro.613619, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=726]], camposKey:0927-3948 2001-01-01 Pars planitis: epidemiology, treatment, and association with multiple sclerosis93102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3565]], camposKey:0365-6691 2001-01-01 Usefulness of conjunctival biopsy as diagnostic technique Utilidad de la biopsia conjuntival como técnica diagnóstica.3136, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=62600]], camposKey:0365-6691 2001-01-01 Usefulness of conjunctival biopsy as diagnostic technique Utilidad de la biopsia conjuntival como técnica diagnóstica3136, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71257]], camposKey:0146-0404 2000-03-15 Pars planitis: Epidemiology, treatment, visual outcome and association with multiple sclerosis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9344]], camposKey:0927-3948 2000-01-01 Corneal perforation due to late radiation therapy-induced corneal necrosis - Clinicopathological correlation6771, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39490]], camposKey:0146-0404 2000-01-01 Human conjunctival epithelial cells express mucin mRNAs in vitro.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71402]], camposKey:0146-0404 1999-03-15 Human epithelial conjunctival primary cultures grown on a biological support00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=724]], camposKey:0271-3683 1999-01-01 Ultrastructural evidence of mucus I human conjunctival epithelial cultures95105, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=721]], camposKey:0277-3740 1998-07-01 Carbomer- versus cellulose-based artificial-tear formulations: Morphologic and toxicologic effects on a corneal cell line433440, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=774]], camposKey:0277-3740 1998-01-01 Analysis of human ocular mucus: Effects of neuraminidase and chitinase enzymes200207, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=734]], camposKey:0271-3683 1998-01-01 Efficacy of topical cyclosporine-loaded nanocapsules on keratoplasty rejection in the rat3946, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=741]], camposKey:1080-7683 1998-01-01 Expression of ICAM-1 and HLA-DR by human conjunctival epithelial cultured cells and modulation by nedocromil sodium517531, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41436]], camposKey:0146-0404 1997-12-01 Evaluation of chitosan as a substitute for the mucus layer of the preocular tear film00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=720]], camposKey:0721-832X 1997-05-01 Characterization of epithelial primary cultures from human conjunctiva268276, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71293]], camposKey:0146-0404 1997-03-15 Evaluation of chitosan as a substitute for the mucus layer of the preocular tear film646646, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3570]], camposKey:0365-6691 1997-01-01 Diagnostic tests of blepharitis-associated dry-eye syndrome. Usefulness of topical anesthesia Test diagnosticos del sindrome de ojo seco asociado a blefaritis, utilidad de la anestesia topica437444, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42610]], camposKey:0365-6691 1997-01-01 Distribución de las uveítis en un centro de referencia665670, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41435]], camposKey:0146-0404 1997-01-01 In vitro study on the toxic effects of carbomer-derived versus carboxymethylcellulose (CMC)-DERI VED artificial tear formulations upon corneal cells00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=735]], camposKey:0146-0404 1997-01-01 In vitro study on the toxic effects of carbomer-derived versus carboxymethylcellulose (CMC)-derived artificial tear formulations upon corneal cells749749, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=667]], camposKey:0927-3948 1997-01-01 Influence of topical anesthesia on tests diagnostic of blepharitis-associated dry eye syndrome3342, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42611]], camposKey:0365-6691 1997-01-01 Tinción diferencial mediante lectinas de la capa mucosa de la película lagrimal precorneal y hongos en un modelo animal de queratitis micótica1116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71302]], camposKey:0146-0404 1996-02-15 Corneal incorporation of exogenous hyaluronic acid on a lamellar keratectomy animal model25342534, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71307]], camposKey:0146-0404 1996-02-15 Nedocromil sodium (NS) modulates ICAM-1 and HLA-DR expression of human conjunctival epithelial cells in vitro226226, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41617]], camposKey:0146-0404 1996-01-01 Corneal incorporation of exogenous hyaluronic acid on a lamellar keratectomy animal model00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42338]], camposKey:0212-6567 1996-01-01 Dry eye syndrome: etiopathology and clinical forms Síndrome de ojo seco: etiopatogenia y formas clínicas.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=709]], camposKey:1081-1206 1996-01-01 Efficacy of nedocromil sodium and cromolyn sodium in an experimental model of ocular allergy124130, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41437]], camposKey:0146-0404 1996-01-01 Nedocromil Sodium (NS) modulates ICAM-1 and HLA-DR expression of human conjunctival epithelial cells in vitro00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=700]], camposKey:0927-3948 1996-01-01 Phlyctenular keratoconjunctivitis - A potentially blinding disorder119123, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71308]], camposKey:0146-0404 1995-03-15 DIFFERENTIAL STAINING OF MUCUS AND FUNGI IN AN ANIMAL-MODEL OF MYCOTIC KERATITIS00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43849]], camposKey:0365-6691 1995-01-01 Actividad antagonista del colirio de ibopamina sobre la miosis intraoperatoria203208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42339]], camposKey:0365-6691 1995-01-01 Activity of ibopamine solution on intraoperative miosis Actividad antagonista del colirio de ibopamina sobre la miosis intraoperatoria203208, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71397]], camposKey:0277-3740 1995-01-01 CALCAREOUS CORNEAL DEGENERATION - REPORT OF 2 CASES97102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41618]], camposKey:0277-3740 1995-01-01 Calcareous corneal degeneration: Report of two cases97102, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42808]], camposKey:1133-7737 1995-01-01 Degeneración esferoidal: correlación clínicopatológica.00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=761]], camposKey:0146-0404 1995-01-01 Effect of the enzymes chitinase and neuraminidase on the structure of human ocular mucus00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40666]], camposKey:0146-0404 1995-01-01 TOPICAL APPLICATION OF NANOCAPSULES OF CYCLOSPORINE-A (CYA) ON A PENETRATING KERATOPLASTY REJECTION MODEL00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71319]], camposKey:0146-0404 1994-03-15 APHAKIC PSEUDOPHAKIC CORNEAL EDEMA (A/PCE) - HISTOPATHOLOGIC STUDY17841784, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=776]], camposKey:0146-0404 1994-01-01 Chromatographic purification of human ocular mucus and structural-analysis by enzymatic means17951795, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3574]], camposKey:0365-6691 1994-01-01 Comparative clinical trial of 2% hydroxypropyl-methylcellulose versus 1% sodium hyaluronate in extracapsular surgery ESTUDIO CLINICO COMPARATIVO DE LA HIDROXIPROPIL-METILCELULOSA 2% QUIRURGICA VERSUS HIALURONATO SODICO 1% EN LA CIRUGIA EXTRACAPSULAR DE CATARATA39, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=43850]], camposKey:0365-6691 1994-01-01 Estudio clínico-comparativo de la hidroxipropil-metilcelulosa 2% quirúrgica versus hialuronato sódico 1% en la cirugía extracapsular de catarata310, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42620]], camposKey:0365-6691 1994-01-01 Factores clínicos que predisponen al fracaso de transplante de cornea: rechazo inmune659666, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71326]], camposKey:0146-0404 1993-03-15 COMPARISON OF THE SENSITIVITY AND SPECIFICITY OF DIAGNOSTIC-TESTS WITH AND WITHOUT TOPICAL ANESTHESIA FOR DRY EYE SYNDROME IN BLEPHARITIS919919, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71328]], camposKey:0146-0404 1993-03-15 EFFICACY OF 2-PERCENT NEDOCROMIL SODIUM COMPARED TO 2-PERCENT SODIUM CROMOGLYCATE IN A MODEL OF ALLERGIC CONJUNCTIVITIS IN THE GUINEA-PIG844844, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71324]], camposKey:0146-0404 1993-03-15 EPIDEMIOLOGIC RISK-FACTORS PREDISPOSING TO CORNEAL ALLOGRAFT FAILURE10981098, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=707]], camposKey:0161-6420 1993-03-01 SURFACE TOXICITY OF TIMOLOL - REPLY293294, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41619]], camposKey:0161-6420 1993-01-01 Authors' reply293294, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=773]], camposKey:0146-0404 1993-01-01 Enzymatic deglycosilation and electrophoretic analysis of the ocular mucus structure14691469, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=655]], camposKey:0146-0404 1992-03-15 EXPERIMENTAL-MODEL OF HAY-FEVER CONJUNCTIVITIS850850, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=71329]], camposKey:0146-0404 1992-03-15 IMPAIRMENT OF THE OCULAR SURFACE OF THE GUINEA-PIG AFTER LONG-TERM TOPICAL TREATMENT12411241, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=42467]], camposKey:0146-0404 1992-01-01 IS CHRONIC APPLICATION OF EYEDROPS RELATED WITH OCULAR ALLERGY850850, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=690]], camposKey:0161-6420 1992-01-01 Ocular Surface Alteration after Long-term Treatment with an Antiglaucomatous Drug10821088, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=692]], camposKey:0146-0404 1991-03-15 ENHANCED OCULAR ANAPHYLAXIS IN THE GUINEA-PIG AFTER LONG-TERM, LOCALLY APPLIED DROPS683683, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=688]], camposKey:0146-0404 1991-03-15 MODIFICATION OF THE OCULAR SURFACE AFTER CHRONIC APPLICATION OF ANTIGLAUCOMATOUS DROPS947947, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3575]], camposKey:0365-6691 1991-01-01 The effect of long-term drug applications on the eye surface8996, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=676]], camposKey:0146-0404 1990-01-01 Pharmacologic modulation of vascular permeability in ocular allergy in the rat176180, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69947]], camposKey:0365-6691 1989-01-01 Endoftalmitis: Análisis de 39 casos.435440, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69931]], camposKey:0365-6691 1988-01-01 Modelo experimental de anafilaxia pasiva conjuntival: Ensayo de fármacos antialérgicos por vía tópica.3344, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=69946]], camposKey:0365-6691 1988-01-01 Valoración de la eficacia del Betaxolol en el glaucoma crónico simple. Influencia sobre la curva tensional.711714][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=19280]},camposKey: 231 262 Cell Therapy Using Extraocular Mesenchymal Stem Cells 978-3-030-01303-5Corneal Regeneration 1 2019-01-01 Springer, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=17069]},camposKey: 103 121 Uveitic glaucoma 978-161470975-6Glaucoma: Etiology, Pathogenesis and Treatments 1 2012-01-01 Nova Science Publishers, CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=113]},camposKey: 643 648 Immunosuppressive chemotherapy for non-infectious uveitis 88-323-0601-8SOE '97 1 1997-01-01 Monduzzi Editore][][Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=122824],camposKey=8494531522El síndrome de ojo seco y su manejo 1 2016-01-01 You and Us}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=102643],camposKey=84-486-0131-9Endoftalmitis: formas clínicas, diagnóstico y tratamiento 1 1996-01-01 McGraw-Hill Interamericana de España}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=102647],camposKey=84-7592-119-1Endoftalmitis 1 1989-01-01 }][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145638314]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636906]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636938]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145633435]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636902]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145625508]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145625232]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30063]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30304]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=932847032]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145624898]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145627395]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145626866]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@a908b76, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@55be4299, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@524554c5, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@758a6d5c][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f83cc, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8f24, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f84a1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d8828, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f940f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f9885, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f821a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f922f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37368f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d71eb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@4d71ec, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f975a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8238, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8d96, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8308, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f926f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8f33, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f981d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f988e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f88ed, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8dc8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f96a0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372619, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37309a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f86ca, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8ad2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8ad6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f885b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8b23, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8db6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3730be, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f81dd, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37300c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372a0e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373e6d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b92, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373ae7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f81e7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372eec, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37522f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5f8710, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d76, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d5a, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d78, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372acc, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d8f][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56fe34], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56f252], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4689b1], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@414e9e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5be9bd], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413358], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412fcd], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41259f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@56f6e0], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5bea33], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4656d2], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413bdc], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4123c6], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@412123], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4122a5], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4120cf], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460721], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411f50], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460600], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411db1], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4120e4], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460477], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411ead], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@411c9f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4127ce], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4127cf], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f38a], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f375], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4134fb]][][CatedrasConvenios{id=22, codigoPersona=com.sigma.fs3.argos.domain.gpc.PersonalGPC[ifcidPers=23489], codigoTipo=CAT, codigoContable=null, titulo=CÁTEDRA ZEISS EN LA UNIVERSIDAD DE VALLADOLID, fechaInicio=2017-09-01, fechaFin=null, importe=12100.0, visiblePortal=1, visibleCvn=1, visibleMemoria=1, validado=S}][][][][][]

AYUDA A LA INVESTIGACIÓN

PUBLICACIONES

Artículos de revista (169)

Perez I.; Galindo S.; Lopez-Miguel A.; Nieto-Miguel T.; de la Mata A.; Lopez-Paniagua M.; Alberca M.; Herreras J.M.; Calonge M. In Vivo Confocal Microscopy in Limbal Stem Cell Deficiency After Mesenchymal Stem Cell Transplantation: A Sub-analysis from a Phase I¿II Clinical Trial . OPHTHALMOLOGY AND THERAPY 2023; 12(6): 3251-3262.

Enlace a la publicación
Ver Todos

Libros (3)

Cocho Archiles, Lidia; Herreras, J.M. El síndrome de ojo seco y su manejo. You and Us; 2016.
Ver Todos

Capítulos de libros (3)

Nieto-Miguel, Teresa ; Galindo, Sara ; López-Paniagua, Marina ; Pérez, Inmaculada ; Herreras, José M. ; Calonge, Margarita. Cell Therapy Using Extraocular Mesenchymal Stem Cells. En: Alió, Jorge L. del Barrio, Jorge L. Alió, Arnalich-Montiel, Francisco. Corneal Regeneration. Springer; 2019. p. 231-262.

Enlace a la publicación

Ver Todos
 

AYUDA A LA INVESTIGACIÓN

Proyectos (29)

CÉLULAS MADRE MESENQUIMALES MODIFICADAS GENÉTICAMENTE PARA MEJORAR SU POTENCIAL COMO TERAPIA CELULAR EN LA SUPERFICIE OCULAR. Equipo Investigadores: DE LA MATA SAMPEDRO, ANA (IP); LOPEZ MIGUEL, ALBERTO (IP); PEREZ SOTO, MARIA INMACULADA. Equipo de Trabajo: FERNANDEZ MARTINEZ, ITZIAR; HERRERAS CANTALAPIEDRA, JOSE MARIA; GALINDO DE LA ROSA, SARA; GARCIA VAZQUEZ, MARIA DEL CARMEN. Personal Contratado: FIGUEROA HARO, JESSICA NATALY. PID2021-125142OA-I00. Entidades Participantes: UNIVERSIDAD DE VALLADOLID (UVa). Entidades Financiadoras: AGENCIA ESTATAL DE INVESTIGACIÓN, FONDOS FEDER, UNION EUROPEA, MICINN. MINISTERIO DE CIENCIA E INNOVACIÓN . 01/09/2022-31/08/2026

FEDERUnión EuropeaMnisterio de Ciencia e InnovaciónAEI
Ver Todos

Convenios/Contratos OTC (46)

Consultas, actos terapéuticos y cirugías complejas en el campo de la oftalmología, servicios de optometría, servicios actividad de genética, servicios de apoyo de enfermería en atención a consultas y adaptación de lentes de contacto. Servicios de enfermería en gestión de proyectos clínicos. Servicios de Patología. . Equipo Investigadores: MALDONADO LÓPEZ, MIGUEL JOSÉ (IP); LOPEZ MIGUEL, ALBERTO; SOBAS ABAD, EVA MARIA; TELLERIA ORRIOLS, JUAN JOSE; CALONGE CANO, MARGARITA; GONZÁLEZ GARCÍA, MARÍA JESÚS; HERRERAS CANTALAPIEDRA, JOSE MARIA; COCO MARTIN, ROSA MARIA; MARTIN HERRANZ, RAUL; PEREZ SOTO, MARIA INMACULADA. Entidades Participantes: FUNDACION GENERAL DE LA UNIVERSIDAD DE VALLADOLID.. Entidades Financiadoras: FUNDACION UNIVERSIDAD DE VALLADOLID.. 01/02/2024

Ver Todos
 

OTROS

Tesis doctorales (13)


Texto completo en acceso abierto  
Ver Todos

Congresos (4)

AYUDAS UVA A LA INVESTIGACION: POSTER: STABILIZATION AFTER CATARACT SURGERY, FLORIDA ( ESTADOS UNIDOS DE AMÉRICA ) 02/05/2010 -
(Asistencia). HERRERAS CANTALAPIEDRA, JOSE MARIA. AYUDAS UVA A LA INVESTIGACION: POSTER: STABILIZATION AFTER CATARACT SURGERY
Ver Todos

Cátedras (1)

CÁTEDRA ZEISS EN LA UNIVERSIDAD DE VALLADOLID. Comisión Mixta Seguimiento: PASTOR BARAJAS, JOSE MARIA (Director); COCO MARTIN, ROSA MARIA; HERRERAS CANTALAPIEDRA, JOSE MARIA; USSA HERRERA, FERNANDO; JUBERIAS SANCHEZ, JOSE RAMON; FERNANDEZ BUENO, IVAN. Entidades Participantes: CARL ZEISS MEDITEC IBERIA SAU. 01/09/2017
Ver Todos
Cargando información ...
Universidad de Valladolid - Copyright Universidad de Valladolid - Todos los derechos reservados